{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:20:44Z","timestamp":1780413644965,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.pupt.2008.12.018","type":"journal-article","created":{"date-parts":[[2009,1,4]],"date-time":"2009-01-04T04:06:07Z","timestamp":1231041967000},"page":"237-242","source":"Crossref","is-referenced-by-count":10,"title":["Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD"],"prefix":"10.1016","volume":"22","author":[{"given":"Arthur F.","family":"Gelb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen Flynn","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Cassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Shinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Schein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noe","family":"Zamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2008.12.018_bib1","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1378\/chest.126.6.1855","article-title":"Simplified detection of dynamic hyperinflation","volume":"126","author":"Gelb","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1164\/ajrccm.158.5.9804004","article-title":"Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease","volume":"158","author":"O'Donnell","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1164\/ajrccm.153.3.8630581","article-title":"Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease","volume":"153","author":"Belman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib4","first-page":"33","article-title":"Chest wall mechanics during exercise in patients with severe chronic airflow obstruction","volume":"12","author":"Dodd","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2008.12.018_bib5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1164\/ajrccm\/148.5.1351","article-title":"Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation","volume":"148","author":"O'Donnell","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2008.12.018_bib6","first-page":"511","article-title":"Pulmonary mechanics during exercise in subjects with chronic airflow obstruction","volume":"49","author":"Stubbing","year":"1980","journal-title":"J Appl Phys"},{"key":"10.1016\/j.pupt.2008.12.018_bib7","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1378\/chest.122.6.2009","article-title":"Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD","volume":"122","author":"Duranti","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnoea, and exercise tolerance in COPD","volume":"23","author":"O'Donnell","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2008.12.018_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1378\/chest.06-1662","article-title":"Tiotropium and simplified detection of dynamic hyperinflation","volume":"131","author":"Gelb","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1378\/chest.124.5.1743","article-title":"Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased lung volumes","volume":"124","author":"Celli","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib11","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO workshop report","author":"Global Initiative for Chronic Obstructive Lung Disease","year":"2001"},{"key":"10.1016\/j.pupt.2008.12.018_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2008.12.018_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1378\/chest.109.2.353","article-title":"Contribution of emphysema and small airways in COPD","volume":"109","author":"Gelb","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.128.3.1168","article-title":"Improvements in symptom-limited exercise performance over 8h with once-daily tiotropium in patients with COPD","volume":"128","author":"Maltais","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib15","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1164\/ajrccm.164.supplement_2.2106061","article-title":"Remodeling in asthma and chronic obstructive lung disease","volume":"164","author":"Jeffery","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib16","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1183\/09031936.00109906","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"29","author":"Celli","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2008.12.018_bib18","series-title":"Asthma and COPD: basic mechanisms and clinical management","first-page":"323","article-title":"Neural and humoral control","author":"Barnes","year":"2002"},{"key":"10.1016\/j.pupt.2008.12.018_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00151829-200403030-00003","article-title":"Role of neutrophils in mucus hypersecretion in COPD and implication for therapy","volume":"3","author":"Kim","year":"2004","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.me.35.020184.002315","article-title":"Autonomic regulation of the airways","volume":"35","author":"Nadel","year":"1984","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/jappl.1971.31.5.651","article-title":"Sympathetic versus parasympathetic nervous regulation of airways in dogs","volume":"31","author":"Cabezas","year":"1971","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pupt.2008.12.018_bib22","first-page":"53","article-title":"Inhaled anticholinergic therapy: applied pharmacology and interesting developments","volume":"2","author":"Witek","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pupt.2008.12.018_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.96.5.984","article-title":"Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects","volume":"96","author":"Gross","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198408163110701","article-title":"Role of parasympathetic system in airway obstruction due to emphysema","volume":"311","author":"Gross","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM198808253190806","article-title":"Ipratropium bromide","volume":"319","author":"Gross","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2125.1978.tb00885.x","article-title":"Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis","volume":"6","author":"Martin","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2008.12.018_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/ajrccm\/141.6.1559","article-title":"Autographic visualization of muscarinic receptor subtypes in humans and guinea pig lung","volume":"141","author":"Mak","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2008.12.018_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1513\/pats.200701-016FM","article-title":"Pharmacologic intervention in chronic obstructive pulmonary disease","volume":"4","author":"Hanania","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2008.12.018_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thx.2006.072777","article-title":"Characterization of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease","volume":"62","author":"Makita","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2008.12.018_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/15412550701601274","article-title":"Computerized tomography phenotypes in severe, early onset chronic obstructive pulmonary disease","volume":"4","author":"Hersh","year":"2007","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2008.12.018_bib31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1164\/ajrccm.155.4.9105069","article-title":"The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema","volume":"155","author":"Eda","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000049367","article-title":"Correlation among the indices of high-resolution computed tomography, pulmonary function tests, pulmonary perfusion scans and exercise tolerance in cases of chronic pulmonary emphysema","volume":"69","author":"Fujita","year":"2002","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2008.12.018_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1076-6332(05)80400-3","article-title":"Quantitative chest computed tomography as a means of predicting exercise performance in severe emphysema","volume":"2","author":"Crausman","year":"1995","journal-title":"Acad Radiol"},{"key":"10.1016\/j.pupt.2008.12.018_bib34","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.rmed.2006.02.003","article-title":"Characteristics of COPD phenotypes classified according to the findings of HRCT","volume":"100","author":"Kitaguchi","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.07-0341","article-title":"Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency","volume":"132","author":"Holme","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1164\/ajrccm.158.3.9801045","article-title":"Pseudophysiologic emphysema resulting from severe small airways disease","volume":"158","author":"Gelb","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib37","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1164\/ajrccm.163.7.2009048","article-title":"Lung function 5 years after lung volume reduction surgery for emphysema","volume":"163","author":"Gelb","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pupt.2006.10.001","article-title":"Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study","volume":"21","author":"Bateman","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2008.12.018_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.129.3.509","article-title":"Effect of tiotropium with and without formeterol on airflow obstruction and resting hyperinflation in patients with chronic obstructive lung disease","volume":"129","author":"VanNoord","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1378\/chest.07-2138","article-title":"Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD","volume":"134","author":"Rabe","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","article-title":"Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of COPD: a randomized trial","volume":"146","author":"Aaron","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2008.12.018_bib42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.123.5.1441","article-title":"Long-term treatment benefit with tiotropium in COPD patients with and without short-term bronchodilator response","volume":"123","author":"Tashkin","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2008.12.018_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/028418502127347448","article-title":"Reproducibility of scoring emphysema by HRCT","volume":"43","author":"Malinen","year":"2002","journal-title":"Acta Radiol"},{"key":"10.1016\/j.pupt.2008.12.018_bib44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1513\/pats.200708-128ET","article-title":"Imaging studies in emphysema","volume":"5","author":"Friedman","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2008.12.018_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-008-1065-z","article-title":"Automated lobar quantification of emphysema in patients with severe chronic\u00a0obstructive pulmonary disease","author":"Revel","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.pupt.2008.12.018_bib46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00330-006-0369-0","article-title":"Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent","volume":"17","author":"Desai","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.pupt.2008.12.018_bib47","article-title":"CT of pulmonary emphysema-current status, challenges and future directions","author":"Litmanovich","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.pupt.2008.12.018_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1164\/ajrccm.159.3.9805067","article-title":"A\u00a0quantification of the lung surface area in emphysema using computed tomography","volume":"159","author":"Coxson","year":"1999","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553908001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553908001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T19:42:27Z","timestamp":1558035747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553908001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1094553908001508"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2008.12.018","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}